Ac-225

Ac-225

Isotope Ac-225 Actinium

Specifications

AVAILABILITY
HALF-LIFE
9.91 days
APPLICATION: Ac-225 is a high energy alpha-emitting radioisotope with therapeutic applications as a Targeted Alpha Therapy (TAT) for certain cancers and HIV.
CHARACTERISTICS: Actinium-225 is a radioactive element with a half-life of 9.91 days emitting alpha particles with emissions at 5,830 keV and 5,792 keV. It decays first into Francium 221, then successively in Astatine-217, Bismuth-213, Thallium-209 and Lead-209 before leading to the stable Bismuth-209.
PROCESS DATA
Medical solutions for nuclear medicine
225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.
Medical solutions for treatment of cancer
Actinium-225 in targeted alpha-particle therapeutic applications
The potential and hurdles of targeted alpha therapy – clinical trials and beyond
The potential and hurdles of targeted alpha therapy – clinical trials and beyond